VerbatimParliament, as it happens

Medical Treatments: Standards

Asked by James McMurdockIndependentDepartment of Health and Social CareTabled Answered 28 April 2026UIN 126287

The question

To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, published on 2 April 2026, what measures are in place to monitor whether the accelerated access to new treatments is translating into measurable improvements in patient outcomes.

Answered by Dr Zubir Ahmed

The Department will continue to work with the National Institute for Health and Care Excellence and NHS England to monitor and assess access to medicines in the United Kingdom and to monitor patient outcomes through the NHS Outcomes Framework Indicators.

There are no plans to routinely monitor the direct impact of accelerated access to new medicines on patient outcomes.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim